Stock Symbol:

NVO

Company Name:

Novo-Nordisk A/S

Company Description:

Novo-Nordisk A/S is a focused healthcare company. In November 2000, all its previous enzyme business activities were spun- off into a separately listed company called Novozymes. Novo Nordisk offers diabetes products, including products within the area of insulin delivery systems.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NYSE

Predicted Split Price:

$108.00

Predicted Split Ratio:

2 for 1

5 Day Performance After Split:

5.1%

Prior Stock Splits:

3

Stock Split History:

18-Apr-94 [4:1], 11-Apr-01 [5:2], 17-Dec-07 [2:1]

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.